ReviewFrontiers in chemistry2026
Carbon-based nanomaterials in biomedicine and technology.
Review in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbon-based nanomaterials (CBNs), including carbon nanotubes (CNTs), fullerenes, and graphene (GN), have attracted significant attention due to their unique structural, electrical, mechanical, and biocompatible properties. Their high surface area, excellent biocompatibility, and tunable physicochemical characteristics enable a wide range of applications, particularly in biomedicine, electronics, energy storage, and optoelectronics. CNTs, with their tensile strength and electrical conductivity, have been extensively studied for tissue engineering, drug delivery, and supercapacitor electrode applications. Despite concerns over their biocompatibility and toxicity, surface functionalization has shown promise in improving their performance and safety. Similarly, fullerenes, owing to their closed-cage structures and high electron affinity, exhibit potent antioxidant and photodynamic therapy capabilities, making them suitable for cancer treatment and optoelectronic devices. GN's high surface area and charge mobility make it ideal for energy storage systems such as supercapacitors and lithium-ion batteries, although its agglomeration tendency limits its practical use unless modified. This work provides a narrative synthesis of recent advancements and practical limitations, outlining future directions for biomedical and technological applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.